Search results
Anti-obesity drugs will be 2024’s defining trend
Pharmaceutical Technology via Yahoo Finance· 5 days agoGlobalData’s latest update notes the impact of the growing anti-obesity market, personalised medicines, real-world evidence,and cell and gene therapies.
FDA to require nutrition labels on front of packages: WF health officials respond
KFDX Wichita Falls· 7 days agoThe Food and Drug Administration is set to propose a change in prepackaged food, and it could change...
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 6 days agoStill, it’s certainly not bad...Chen wrote Monday. It’s even more significant for Biogen and Eisai....
Palatin Technologies commences Phase II study of obesity treatment
Clinical Trials Arena via Yahoo Finance· 4 days agoPalatin Technologies has commenced a Phase II clinical trial of breatelanotide, a melanocortin 4...
Novo’s blockbuster obesity drug Wegovy under fire in Denmark
Detroit News· 4 days agodrug oversight panel advised doctors to restrict prescriptions of Novo Nordisk A/S’s blockbuster ...
Could Structure Therapeutics Become the Next Novo Nordisk? | The Motley Fool
The Motley Fool· 8 hours agoStructure Therapeutics (GPCR 0.48%) and Novo Nordisk (NVO -1.21%) have one big thing in common: the...
Weight loss injectables popularity steadily increase
WYMT Eastern Kentucky· 1 day agoIn March of 2024, the Food and Drug Administration approved injectables containing semaglutide to be used for weight ...
Texas patients turn to clinics for compounded semaglutide with Ozempic and WeGovy scarce
Dallas Morning News· 11 hours agoIt was photos from a cruise trip that finally pushed Joelle Potter to the breaking point in her...
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
Motley Fool via Yahoo Finance· 2 days agoThat's understandable. The drugmaker is a leader in these areas,and its most recent medicines,...
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 5 days agoBlue Cross Blue Shield of Michigan is dropping coverage of popular weight loss drugs, citing...